Fang Wang

Also affiliated with Cancer Hospital of Chinese Academy of Medical Sciences, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy”.

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3305

N/A

0.725DataRank · unranked

125 citations

Pasi A. Jänne, Mateusz Opyrchal, Navid Hafez, Luis E. Raez, Dmitry I. Gabrilovich +15 more

HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.04.463081

N/A

0.165DataRank · unranked

2 citations

Ka-wing Fong, Fang Wang, Galina Gritsina, Sylvan C. Baca, Jacob E. Berchuck +9 more

Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells

Molecular Cancer(2020)10.1186/s12943-020-01254-x

N/A

0DataRank · unranked

32 citations

Marcia Bellon, Fang Wang, Hong Zhang, Liwu Fu, Christophe Nicot +1 more